The overall hypothesis that forms the basis of this proposal is that an interaction between the amyloid beta-protein (Abeta) and the amyloid beta-protein precursor (AbetaPP), and the cell surface in human cerebrovascular smooth muscle (HCSM) cells is involved in the initiation and progression of the cerebrovascular smooth muscle cellular pathology of Alzheimer's disease (AD) and related disorders including hereditary cerebral hemorrhage with amyloidosis Dutch-type (HCHWA-D). The applicants' overall research efforts have focused on elucidating the cellular mechanism that underlie the cerebrovascular pathology of AD, HCHWA-D and related disorders. The objectives of the present proposal are to investigate a recently identified interaction between certain forms of Abeta and cellular AbetaPP in cultured HCSM cells that induce several key pathologic responses in these cells. This mechanism may be specific for HSCM and related cells in the cerebral blood vessel wall and, therefore, may help to explain the different etiologies between the parenchymal and cerebrovascular Abeta induced pathologies in AD and relates disorder. They plan to identify the precise domain on AbetaPP where Abeta binds to induce the pathologic responses in HCSM cells. Investigations will be conducted to determine if AbetaPP is implicated in cell-surface Abeta fibril formation and if these fibrils are involved with promoting the pathological responses in HCSM cells. Lastly, they will determine if altering the endogenous level of AbetaPP expression affects the ability of Abeta to induce pathologic responses in HCSM cells. These combined investigations intend to utilize cultured HCSM cells as an in vitro paradigm to identify the Abeta binding site on AbetaPP and characterize the consequences of this interaction on the cells surface that potentially leads to the initiation and progression of the cerebrovascular smooth muscle cellular pathology of AD, HCHWA-D and related disorders. Although early in its discovery, the pathologic interaction between Abeta and AbetaPP in HCSM cells have potential therapeutic implications. Identification of the precise Abeta binding site on AbetaPP and determining the nature of the interactions that are involved with inducing the key pathologic responses may provide an opportunity for the future development of novel intervention strategies to block the initiation and/or halt the further progression of the cerebrovascular pathology of AD, HCHWA-D, and related disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS035781-02
Application #
2714616
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Program Officer
Oliver, Eugene J
Project Start
1997-09-30
Project End
2000-05-31
Budget Start
1998-06-01
Budget End
1999-05-31
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Kotarba, Annmarie E; Aucoin, Darryl; Hoos, Michael D et al. (2013) Fine mapping of the amyloid ýý-protein binding site on myelin basic protein. Biochemistry 52:2565-73
Ahmed, Mahiuddin; Davis, Judianne; Aucoin, Darryl et al. (2010) Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat Struct Mol Biol 17:561-7
Liao, Mei-Chen; Hoos, Michael D; Aucoin, Darryl et al. (2010) N-terminal domain of myelin basic protein inhibits amyloid beta-protein fibril assembly. J Biol Chem 285:35590-8
Liao, Mei-Chen; Ahmed, Mahiuddin; Smith, Steven O et al. (2009) Degradation of amyloid beta protein by purified myelin basic protein. J Biol Chem 284:28917-25
Hoos, Michael D; Ahmed, Mahiuddin; Smith, Steven O et al. (2007) Inhibition of familial cerebral amyloid angiopathy mutant amyloid beta-protein fibril assembly by myelin basic protein. J Biol Chem 282:9952-61
Wilhelmus, Micha M M; Otte-Holler, Irene; Davis, Judianne et al. (2005) Apolipoprotein E genotype regulates amyloid-beta cytotoxicity. J Neurosci 25:3621-7
Yamamoto, Naoki; Hirabayashi, Yoshio; Amari, Masakuni et al. (2005) Assembly of hereditary amyloid beta-protein variants in the presence of favorable gangliosides. FEBS Lett 579:2185-90
Jung, Sonia S; Van Nostrand, William E (2003) Humanin rescues human cerebrovascular smooth muscle cells from Abeta-induced toxicity. J Neurochem 84:266-72
Jung, Sonia S; Zhang, Weibing; Van Nostrand, William E (2003) Pathogenic A beta induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells. J Neurochem 85:1208-15
Davis, Judianne; Wagner, Matthew R; Zhang, Weibing et al. (2003) Amyloid beta-protein stimulates the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells. J Biol Chem 278:19054-61

Showing the most recent 10 out of 20 publications